tiprankstipranks
Iovance Biotherapeutics Inc (GB:0JDK)
LSE:0JDK

Iovance Biotherapeutics (0JDK) Stock Investors

2 Followers
Based on 722,977 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

0.3% of all portfolios hold GB:0JDK
On average, investors allocate 4.76% of their portfolios to GB:0JDK
The average holding size of this company in investors' portfolios.

Investor Sentiment

Very Positive
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 722,977 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding 0JDK

0.7%
Last 7
Days
14.3%
Last 30
Days
Percentages indicate the change in the number of portfolios holding GB:0JDK, out of 722,977 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

0JDK Investor Activity

No data currently available
Based on the activity of 13,599 investors who made their portfolios public
The table shows changes in 0JDK in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

0JDK Investors Also Bought

Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
DraftKings
7.22%
+0.86%
+1.66%
40.91B
Consumer Cyclical
Micron
5.59%
+10.90%
+26.10%
122.04B
Technology
Trade Desk
4.72%
+0.67%
+1.32%
41.59B
Technology
Block
4.54%
-0.39%
+0.31%
49.73B
Technology
Merck & Company
4.04%
+0.19%
+0.58%
313.67B
Healthcare
Marvell
4.73%
+2.09%
+11.09%
57.62B
Technology
Mercadolibre
5.42%
-0.27%
+3.93%
79.70B
Consumer Cyclical
ServiceNow
3.99%
+1.69%
+7.01%
158.70B
Technology
Salesforce
4.82%
+0.35%
+5.59%
298.54B
Technology
Riot Platforms
4.98%
+0.99%
+6.18%
2.89B
Financial
Based on the activity of 722,977 active portfolios
Open your Smart Portfolio

0JDK Investor Analysis

GB:0JDK investors under 35

Under 35

23.6%
Last 30 days
Holdings Change
9.8%
of GB:0JDK holders
are under 35
Average Segment Performance
Average P/E Ratio56.24
Beta7.70
Dividend Yield5.72%
GB:0JDK investors between 35–55

Between 35–55

17.3%
Last 30 days
Holdings Change
50.6%
of GB:0JDK holders
are between 35–55
Average Segment Performance
Average P/E Ratio61.68
Beta11.71
Dividend Yield6.34%
GB:0JDK investors over 55

Over 55

10.9%
Last 30 days
Holdings Change
39.6%
of GB:0JDK holders
are over 55
Average Segment Performance
Average P/E Ratio53.31
Beta6.02
Dividend Yield6.03%
Overview of age group and performance of GB:0JDK stock investors
See who invests in 0JDK according to age group and performance.

FAQ

How many retail Investors hold GB:0JDK?
0.3% of TipRanks' retail investors hold GB:0JDK in their portfolios.
    What is GB:0JDK Investor Sentiment?
    GB:0JDK’s Investor Sentiment is Very Positive.
      What percentage of retail investors changed their holding of GB:0JDK in the last 7 days?
      ▲ 0.7% of TipRanks' retail investors changed their holding of GB:0JDK in the last 7 days.
        What percentage of retail investors changed their holding of GB:0JDK in the last 30 days?
        ▲ 14.3% of TipRanks' retail investors changed their holding of GB:0JDK in the last 30 days.
          What is the average age of retail investors who hold GB:0JDK?
          The average age of GB:0JDK Holders is between 35–55.
            What other stocks have GB:0JDK investors also bought?
            GB:0JDK Investors also bought DKNG, MU, TTD, SQ, MRK, MRVL, MELI, NOW, CRM, RIOT.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              ABTAbbott Labs
              ATECAlphatec Holdings
              CORCencora
              AZNAstraZeneca
              NOTVInotiv
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis